NEW YORK (GenomeWeb News) – Less than a year after surpassing 300 employees, the Seattle Biomedical Research Institute will be "shooting for 400" in the new year by expanding its work in immunology and systems biology, as well as continuing its research programs in malaria, HIV, tuberculosis, and neglected trypanosomatid diseases, President and Director Ken Stuart told GenomeWeb Daily News this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.